Fernandes C J, Ackerman V P
Department of Microbiology, RNS Hospital, St. Leonards, Australia.
Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):153S-157S. doi: 10.1016/0732-8893(89)90128-4.
A survey of antibiotic resistance in Australian states was undertaken by the Microbiology Quality Assurance Program of the Royal College of Pathologists of Australasia. Data were obtained from hospitals and private pathology laboratories serving both in-patients and out-patients at community hospitals. The study showed that resistance varied from state to state; it was highest in the Eastern states of New South Wales, Victoria, and Queensland, and lowest in Tasmania and Western Australia. In South Australia, isolates of Escherichia coli demonstrated a high degree of cefoxitin resistance. Western Australia and Tasmania showed high levels of gentamicin resistance for Klebsiella spp., as well as trimethoprim resistance in Proteus mirabilis. The relationship between erythromycin resistance and clindamycin resistance also differed among various states. These studies demonstrated the activity of sulbactam/ampicillin against a wide variety of common pathogenic bacteria in which resistance was mediated by beta-lactamase.
澳大利亚皇家病理学家学会微生物质量保证项目对澳大利亚各州的抗生素耐药性进行了一项调查。数据来自为社区医院的住院患者和门诊患者服务的医院及私立病理实验室。研究表明,耐药性因州而异;在新南威尔士州、维多利亚州和昆士兰州等东部各州最高,而在塔斯马尼亚州和西澳大利亚州最低。在南澳大利亚州,大肠杆菌分离株显示出对头孢西丁的高度耐药性。西澳大利亚州和塔斯马尼亚州的克雷伯菌属对庆大霉素呈现出高耐药水平,奇异变形杆菌对甲氧苄啶也有耐药性。不同州之间红霉素耐药性与克林霉素耐药性的关系也有所不同。这些研究证明了舒巴坦/氨苄西林对多种常见病原菌的活性,这些病原菌的耐药性是由β-内酰胺酶介导的。